ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Orlando, FL, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Orlando, Florida, United States and 44 other locations

placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...

Enrolling
Diabetes, Type II
Obesity
Drug: AZD6234
Drug: Placebo to match

Phase 2

AstraZeneca
AstraZeneca

Winter Park, Florida, United States and 17 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Mount Dora, Florida, United States of America and 24 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Sanford, Florida, United States and 81 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Port Orange, Florida, United States of America and 78 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Orlando, Florida, United States and 187 other locations

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

Orlando, Florida, United States and 96 other locations

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors ...

Enrolling
Type 2 Diabetes
Cortisol Excess
Drug: clofutriben
Drug: Placebo

Phase 2

Sparrow Pharmaceuticals

Port Orange, Florida, United States of America and 41 other locations

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilint...

Enrolling
Type 2 Diabetes
Overweight
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Phase 3

Novo Nordisk
Novo Nordisk

Kissimmee, Florida, United States and 66 other locations

The purpose of this study is to see how well LY3938577 works and how safe it is compared to degludec in people with type 2 diabetes. Partici...

Enrolling
Diabetes Mellitus, Type 2
Drug: Degludec
Drug: LY3938577

Phase 2

Lilly
Lilly

Lakeland, Florida, United States and 25 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems